Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Medikamentöse systemtherapie des melanoms
Translated title of the contribution
:
Pharmaceutical systemic therapy of melanoma
D. Schadendorf
, H. Bernhard
Animal and Food Sciences
Cardiovascular Research Priority Area
Diabetes & Obesity Research Priority Area
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmaceutical systemic therapy of melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Melanoma
100%
Systemic Therapy
100%
Metastatic Melanoma
50%
Clinical Study
25%
Overall Survival
25%
MEK Inhibitor
25%
Blocking Antibody
25%
Treatment Option
25%
Neoplasm
12%
Metastatic Carcinoma
12%
CTLA-4
12%
Ipilimumab
12%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Metastatic Melanoma
50%
Clinical Study
25%
Overall Survival
25%
Mitogen Activated Protein Kinase Kinase Inhibitor
25%
Blocking Antibody
25%
Systemic Treatment
12%
Neoplasm
12%
Ipilimumab
12%
Cytotoxic T Lymphocyte Antigen 4
12%